<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="82447">
  <stage>Registered</stage>
  <submitdate>27/11/2007</submitdate>
  <approvaldate>12/12/2007</approvaldate>
  <actrnumber>ACTRN12607000630415</actrnumber>
  <trial_identification>
    <studytitle>The Effect of a Novel Nasal Airflow System on Sleep Quality &amp; Perception</studytitle>
    <scientifictitle>Comparison of nasal airflow via cannula vs nasal pressure via mask on sleep quality and perception in mild to moderate obstructive sleep apnoea</scientifictitle>
    <utrn />
    <trialacronym />
  </trial_identification>
  <conditions>
    <healthcondition>Mild or moderate obstructive sleep apnoea</healthcondition>
    <conditioncode>
      <conditioncode1>Respiratory</conditioncode1>
      <conditioncode2>Sleep apnoea</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>Constant airflow administered via nasal cannual to deliver pharyngeal pressure &lt;4 cm H20 for 8 hours during 1 night.</interventions>
    <comparator>Constant air pressure administered via nasal mask to deliver pharyngeal pressure &gt;4 cm H2O for 8 hours during 1 night.</comparator>
    <control>Active</control>
    <interventioncode>Treatment: Devices</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>respiratory disturbance index</outcome>
      <timepoint>at baseline and immediately following intervention</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>arousal index</outcome>
      <timepoint>at baseline and immediately following intervention</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>apnoea hypopnoea index &lt;30</inclusivecriteria>
    <inclusiveminage>18</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage>100</inclusivemaxage>
    <inclusivemaxagetype>Years</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>Yes</healthyvolunteer>
    <exclusivecriteria>Other acute or chronic respiratory illness including but not limited to: Chronic obstructive pulmonary disease &amp; asthma</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Treatment</purpose>
    <allocation>Randomised controlled trial</allocation>
    <concealment />
    <sequence />
    <masking />
    <assignment />
    <designfeatures />
    <endpoint />
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase />
    <anticipatedstartdate>15/12/2007</anticipatedstartdate>
    <actualstartdate />
    <anticipatedenddate />
    <actualenddate />
    <samplesize>15</samplesize>
    <actualsamplesize />
    <recruitmentstatus>Not yet recruiting</recruitmentstatus>
    <recruitmentcountry>Australia</recruitmentcountry>
    <recruitmentstate />
    <postcode>6009</postcode>
  </recruitment>
  <sponsorship>
    <primarysponsortype>Hospital</primarysponsortype>
    <primarysponsorname>Sir Charles Gairdner Hospital</primarysponsorname>
    <primarysponsoraddress>Hospital Avenue
NEDLANDS, WA 6009</primarysponsoraddress>
    <primarysponsorcountry>Australia</primarysponsorcountry>
    <fundingsource>
      <fundingtype>Self funded/Unfunded</fundingtype>
      <fundingname />
      <fundingaddress />
      <fundingcountry />
    </fundingsource>
    <secondarysponsor>
      <sponsortype>None</sponsortype>
      <sponsorname />
      <sponsoraddress />
      <sponsorcountry />
    </secondarysponsor>
  </sponsorship>
  <ethicsAndSummary>
    <summary>The study is being conducted to determine the effect of a novel treatment for sleep apnoea, using a nasal airflow cannula to raise phayngeal pressure. The outcomes assessed will be objective measures of sleep quality, as well as patient assessment of sleep quality. The treatment will be compared to CPAP, which is the current standard treatment for sleep apnoea.</summary>
    <trialwebsite />
    <publication />
    <ethicsreview>Approved</ethicsreview>
    <publicnotes />
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title />
      <name>Dr Jason Kirkness</name>
      <address>Department of Pulmonary Physiology
Level 5, G Block
Sir Charles Gairdner</address>
      <phone>(08) 9346 3154</phone>
      <fax>(08) 9346 2034</fax>
      <email>Jason.Kirkness@health.wa.gov.au</email>
      <country>Australia</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title />
      <name>Dr Jason Kirkness</name>
      <address>Department of Pulmonary Physiology
Level 5, G Block
Sir Charles Gairdner</address>
      <phone>(08) 9346 3154</phone>
      <fax>(08) 9346 2034</fax>
      <email>Jason.Kirkness@health.wa.gov.au</email>
      <country>Australia</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title />
      <name>Dr Jason Kirkness</name>
      <address>Department of Pulmonary Physiology
Level 5, G Block
Sir Charles Gairdner</address>
      <phone>(08) 9346 3154</phone>
      <fax>(08) 9346 2034</fax>
      <email>Jason.Kirkness@health.wa.gov.au</email>
      <country>Australia</country>
      <type>Updating Information</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Principal Investigator</type>
    </contact>
  </contacts>
</ANZCTR_Trial>